BIOMAT Database Logo BIOMAT Database Logo

Transforming growth factor beta-induced connective tissue growth factor and chronic allograft rejection. 2006

K Csencsits, and S C Wood, and G Lu, and S M Faust, and D Brigstock, and E J Eichwald, and C G Orosz, and D K Bishop
Section of General Surgery, Department of Surgery, University of Michigan School of Medicine, Ann Arbor, MI 48109, USA.

Late loss of allograft function is primarily attributed to chronic rejection (CR). There are no effective treatments for CR and the underlying cause of the disease is unknown. This study compared events that occurred within cardiac allografts placed in mice that received either anti-CD4 therapy and develop CR or anti-CD40L therapy and do not develop CR. Both TGFbeta and connective tissue growth factor (CTGF), which is induced by TGFbeta, were expressed in grafts with CR but were not expressed in grafts without CR. TGFbeta transfection of allografts in anti-CD40L-treated recipients resulted in CTGF expression and CR. However, TGFbeta transfection of syngeneic grafts did not result in CTGF expression or CR. These data indicate that TGFbeta alone is insufficient to induce CR and that CTGF is required. Further, antigenic stimulation is required for TGFbeta induction of CTGF. Thus, CTGF may serve as a therapeutic target for CR.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D014185 Transplantation, Isogeneic Transplantation between genetically identical individuals, i.e., members of the same species with identical histocompatibility antigens, such as monozygotic twins, members of the same inbred strain, or members of a hybrid population produced by crossing certain inbred strains. Transplantation, Syngeneic,Isogeneic Transplantation,Isograft Transplantation,Isografting,Syngeneic Transplantation,Transplantation, Isograft

Related Publications

K Csencsits, and S C Wood, and G Lu, and S M Faust, and D Brigstock, and E J Eichwald, and C G Orosz, and D K Bishop
Transforming growth factor beta prevents islet allograft rejection.
February 1991, Transplantation proceedings,
K Csencsits, and S C Wood, and G Lu, and S M Faust, and D Brigstock, and E J Eichwald, and C G Orosz, and D K Bishop
Transforming growth factor-beta polymorphisms and cardiac allograft rejection.
October 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
K Csencsits, and S C Wood, and G Lu, and S M Faust, and D Brigstock, and E J Eichwald, and C G Orosz, and D K Bishop
Induction of transforming growth factor-beta during cardiac allograft rejection.
July 1993, Journal of immunology (Baltimore, Md. : 1950),
K Csencsits, and S C Wood, and G Lu, and S M Faust, and D Brigstock, and E J Eichwald, and C G Orosz, and D K Bishop
Transforming growth factor-beta/connective tissue growth factor axis in the kidney.
January 2008, The international journal of biochemistry & cell biology,
K Csencsits, and S C Wood, and G Lu, and S M Faust, and D Brigstock, and E J Eichwald, and C G Orosz, and D K Bishop
Increased connective tissue growth factor expression in a rat model of chronic heart allograft rejection.
March 2009, Journal of the Formosan Medical Association = Taiwan yi zhi,
K Csencsits, and S C Wood, and G Lu, and S M Faust, and D Brigstock, and E J Eichwald, and C G Orosz, and D K Bishop
Connective tissue growth factor is responsible for transforming growth factor-beta-induced peritoneal mesothelial cell apoptosis.
January 2006, Nephron. Experimental nephrology,
K Csencsits, and S C Wood, and G Lu, and S M Faust, and D Brigstock, and E J Eichwald, and C G Orosz, and D K Bishop
Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP.
October 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
K Csencsits, and S C Wood, and G Lu, and S M Faust, and D Brigstock, and E J Eichwald, and C G Orosz, and D K Bishop
Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis.
November 2001, Current opinion in rheumatology,
K Csencsits, and S C Wood, and G Lu, and S M Faust, and D Brigstock, and E J Eichwald, and C G Orosz, and D K Bishop
Neutralizing monoclonal antibody to human connective tissue growth factor ameliorates transforming growth factor-beta-induced mouse fibrosis.
September 2008, Journal of cellular physiology,
K Csencsits, and S C Wood, and G Lu, and S M Faust, and D Brigstock, and E J Eichwald, and C G Orosz, and D K Bishop
Does transforming growth factor beta 1 play a role in the pathogenesis of chronic allograft rejection?
January 1999, Transplant international : official journal of the European Society for Organ Transplantation,
Copied contents to your clipboard!